JP2007512381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512381A5 JP2007512381A5 JP2006541869A JP2006541869A JP2007512381A5 JP 2007512381 A5 JP2007512381 A5 JP 2007512381A5 JP 2006541869 A JP2006541869 A JP 2006541869A JP 2006541869 A JP2006541869 A JP 2006541869A JP 2007512381 A5 JP2007512381 A5 JP 2007512381A5
- Authority
- JP
- Japan
- Prior art keywords
- arthritis
- medicament
- combination
- rheumatoid arthritis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0327840.5A GB0327840D0 (en) | 2003-12-01 | 2003-12-01 | Organic compounds |
| PCT/EP2004/013587 WO2005053661A2 (en) | 2003-12-01 | 2004-11-30 | Pharmaceutical combinations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007512381A JP2007512381A (ja) | 2007-05-17 |
| JP2007512381A5 true JP2007512381A5 (https=) | 2008-01-24 |
Family
ID=29798110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541869A Pending JP2007512381A (ja) | 2003-12-01 | 2004-11-30 | 医薬的組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070117833A1 (https=) |
| EP (1) | EP1819361A2 (https=) |
| JP (1) | JP2007512381A (https=) |
| KR (1) | KR20060122877A (https=) |
| CN (1) | CN1886157A (https=) |
| AU (1) | AU2004294282B2 (https=) |
| BR (1) | BRPI0417146A (https=) |
| CA (1) | CA2546738A1 (https=) |
| GB (1) | GB0327840D0 (https=) |
| RU (1) | RU2006123312A (https=) |
| WO (1) | WO2005053661A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1478648E (pt) | 2002-02-01 | 2014-07-15 | Ariad Pharma Inc | Compostos contendo fósforo e suas utilizações |
| WO2006053754A1 (en) * | 2004-11-19 | 2006-05-26 | Novartis Ag | COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE |
| WO2007059106A2 (en) * | 2005-11-14 | 2007-05-24 | Ariad Gene Therapeutics, Inc. | Administration of mntor inhibitor to treat patients with cancer |
| EP1880723A1 (en) * | 2006-07-14 | 2008-01-23 | Novartis AG | Combination of mTOR inhibitor and antifolate compound |
| WO2007080124A1 (en) * | 2006-01-12 | 2007-07-19 | Novartis Ag | Combination of mtor inhibitor and antipolate compound |
| KR20080090493A (ko) * | 2006-02-02 | 2008-10-08 | 노파르티스 아게 | 결절성 경화증의 치료 |
| US20090023768A1 (en) * | 2006-02-24 | 2009-01-22 | Novartis Ag | Rapamycin derivatives for treating neuroblastoma |
| JP2010509400A (ja) | 2006-11-14 | 2010-03-25 | アリアド・ファーマシューティカルズ・インコーポレイテッド | 経口処方組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| US5258389A (en) * | 1992-11-09 | 1993-11-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives |
| US5985890A (en) * | 1995-06-09 | 1999-11-16 | Novartis Ag | Rapamycin derivatives |
| GB0123025D0 (en) * | 2001-09-25 | 2001-11-14 | Eirx Therapeutics Ltd | Apoptosis |
| BR0306858A (pt) * | 2002-01-10 | 2004-11-03 | Novartis Ag | Sistemas de liberação de drogas para a prevenção e tratamento de doenças vasculares compreendendo rapamicina e derivados da mesma |
| PT1478648E (pt) * | 2002-02-01 | 2014-07-15 | Ariad Pharma Inc | Compostos contendo fósforo e suas utilizações |
| WO2003106622A2 (en) * | 2002-05-30 | 2003-12-24 | The Children's Hospital Of Philadelphia | Methods for treatment of acute lymphocytic leukemia |
| TW200509958A (en) * | 2003-02-14 | 2005-03-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
-
2003
- 2003-12-01 GB GBGB0327840.5A patent/GB0327840D0/en not_active Ceased
-
2004
- 2004-11-30 RU RU2006123312/15A patent/RU2006123312A/ru not_active Application Discontinuation
- 2004-11-30 CN CNA2004800355130A patent/CN1886157A/zh active Pending
- 2004-11-30 CA CA002546738A patent/CA2546738A1/en not_active Abandoned
- 2004-11-30 US US10/581,069 patent/US20070117833A1/en not_active Abandoned
- 2004-11-30 AU AU2004294282A patent/AU2004294282B2/en not_active Expired - Fee Related
- 2004-11-30 KR KR1020067010547A patent/KR20060122877A/ko not_active Withdrawn
- 2004-11-30 BR BRPI0417146-2A patent/BRPI0417146A/pt not_active IP Right Cessation
- 2004-11-30 WO PCT/EP2004/013587 patent/WO2005053661A2/en not_active Ceased
- 2004-11-30 EP EP04803369A patent/EP1819361A2/en not_active Withdrawn
- 2004-11-30 JP JP2006541869A patent/JP2007512381A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10561618B2 (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders | |
| JP5796959B2 (ja) | 関節炎における痛みの治療のためのタペンタドール | |
| JP2000507544A (ja) | 痛みの治療方法 | |
| WO2016062283A1 (zh) | 抗发炎用药物在制备抑制癌症的医药组合物中的应用 | |
| JP2013521304A5 (https=) | ||
| CN102781240A (zh) | 用拉喹莫德和甲氨蝶呤的组合治疗类风湿性关节炎 | |
| JP2008539250A (ja) | アテローム性動脈硬化症を処置するための方法 | |
| JP2007512381A5 (https=) | ||
| JP2020519576A5 (https=) | ||
| EP3007693A1 (en) | Pharmaceutical combinations of a pi3k inhibitor and a microtubule destabilizing agent | |
| JP2016505050A5 (https=) | ||
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| US10576076B2 (en) | Pharmaceutical combination of everolimus with dactolisib | |
| HRP20251043T1 (hr) | Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća | |
| Kris et al. | Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin. | |
| Kumar et al. | Cilostazol: a new drug in the treatment intermittent claudication | |
| US20110269755A1 (en) | Compositions and methods for treating vascular, autoimmune, and inflammatory diseases | |
| AU2007234917B2 (en) | Renin inhibitors for the treatment of hypertension | |
| EP3789020A1 (en) | Fixed dose composition of paracetamol: amitriptyline and method for the treatment of mixed cancer pain | |
| JP2008527034A5 (https=) | ||
| MX2024004372A (es) | Formulacion oral. | |
| ZA202206042B (en) | Treating behavioral and psychological symptoms in dementia patients | |
| WO2017017511A1 (en) | Modified release formulation for treating premature ejaculation | |
| JP2004244347A (ja) | イトラコナゾール併用剤 | |
| HK1207285B (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders |